dc.creatorCooke, Mariana
dc.creatorKreider Letterman, Gabriel
dc.creatorBaker, Martin James
dc.creatorZhang, Suli
dc.creatorSullivan, Neil T.
dc.creatorEruslanov, Evgeniy
dc.creatorAbba, Martín Carlos
dc.creatorGoicoechea, Silvia M.
dc.creatorGarcia Mata, Rafael
dc.creatorKazanietz, Marcelo Gabriel
dc.date.accessioned2022-01-28T17:52:15Z
dc.date.accessioned2022-10-15T14:20:20Z
dc.date.available2022-01-28T17:52:15Z
dc.date.available2022-10-15T14:20:20Z
dc.date.created2022-01-28T17:52:15Z
dc.date.issued2021-11
dc.identifierCooke, Mariana; Kreider Letterman, Gabriel; Baker, Martin James; Zhang, Suli; Sullivan, Neil T.; et al.; FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma; Elsevier; Cell Reports; 37; 5; 11-2021; 1-24
dc.identifier2211-1247
dc.identifierhttp://hdl.handle.net/11336/150901
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4396166
dc.description.abstractDespite the undisputable role of the small GTPase Rac1 in the regulation of actin cytoskeleton reorganization, the Rac guanine-nucleotide exchange factors (Rac-GEFs) involved in Rac1-mediated motility and invasion in human lung adenocarcinoma cells remain largely unknown. Here, we identify FARP1, ARHGEF39, and TIAM2 as essential Rac-GEFs responsible for Rac1-mediated lung cancer cell migration upon EGFR and c-Met activation. Noteworthily, these Rac-GEFs operate in a non-redundant manner by controlling distinctive aspects of ruffle dynamics formation. Mechanistic analysis reveals a leading role of the AXL-Gab1-PI3K axis in conferring pro-motility traits downstream of EGFR. Along with the positive association between the overexpression of Rac-GEFs and poor lung adenocarcinoma patient survival, we show that FARP1 and ARHGEF39 are upregulated in EpCam+ cells sorted from primary human lung adenocarcinomas. Overall, our study reveals fundamental insights into the complex intricacies underlying Rac-GEF-mediated cancer cell motility signaling, hence underscoring promising targets for metastatic lung cancer therapy.
dc.languageeng
dc.publisherElsevier
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.celrep.2021.109905
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S2211124721013759?via%3Dihub
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectARHGEF39
dc.subjectAXL
dc.subjectEGFR
dc.subjectFARP1
dc.subjectLUNG CANCER
dc.subjectMIGRATION
dc.subjectRAC-GEF
dc.subjectRAC1
dc.subjectRUFFLES
dc.subjectTIAM2
dc.titleFARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución